Elemental impurities remain a critical consideration in pharmaceutical quality systems because trace metal contaminants can affect product safety, regulatory compliance, and overall product quality. To manage these risks, pharmaceutical manufacturers are expected to follow the principles outlined in ICH Q3D, which provides a risk-based framework for evaluating and controlling elemental impurities. However, one of the […]